Ursolic Acid attenuates HMGB1-induced LOX-1 expression in vascular endothelial cells in vitro and inhibits atherogenesis in hypercholesterolemic mice in vivo

Medicine and Dentistry

• In Vitro 100%
• Vascular Endothelial Cell 100%
• Atherogenesis 100%
• Ursolic Acid 100%
• Endothelial Cell 60%
• Oxidized Low Density Lipoprotein 60%
• Coronary Artery 30%
• Scavenger Receptor BI 20%
• Cell Receptor 20%
• Scavenger Receptor 20%
• Antioxidant 10%
• Nitric Oxide 10%
• Therapeutic Agent 10%
• Atherosclerosis 10%
• Antiinflammatory Activity 10%
• Cyclooxygenase 2 10%
• Hypercholesterolemia 10%
• Vasculitis 10%
• Mediator 10%
• Endothelial Dysfunction 10%
• Oxidized Low Density Lipoprotein Receptor 1 10%
• Oxidized Low Density Lipoprotein Receptor 10%
• Lipid Absorption 10%
• Triterpenoid 10%
• Signal Transduction 10%
• Adipocyte 10%
• Lipolysis 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse 100%
• Atherogenesis 100%
• Ursolic Acid 100%
• Oxidized Low Density Lipoprotein 60%
• Scavenger Receptor BI 20%
• Scavenger Receptor 20%
• Cell Receptor 20%
• Cyclooxygenase 2 10%
• Atherosclerosis 10%
• Antiinflammatory Activity 10%
• Herb 10%
• Triterpenoid 10%
• Oxidized Low Density Lipoprotein Receptor 1 10%
• Oxidized Low Density Lipoprotein Receptor 10%
• Antioxidant 10%
• Vasculitis 10%
• Endothelial Dysfunction 10%
• Nitric Oxide 10%
• Hypercholesterolemia 10%